Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer

被引:226
作者
Hwang, RF
Krishnamurthy, S
Hunt, KK
Mirza, N
Ames, FC
Feig, B
Kuerer, HM
Singletary, SE
Babiera, G
Meric, F
Akins, JS
Neely, J
Ross, MI
机构
[1] UT MD Anderson Canc Ctr, Surg Breast Sect, Houston, TX 77030 USA
[2] UT MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] UT MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
sentinel lymph node; predictive factors; axillary dissection; breast cancer;
D O I
10.1245/ASO.2003.05.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is unclear which breast cancer patients with positive sentinel lymph nodes (SLNs) require a completion axillary lymph node dissection. Our aim was to determine factors that,predict involvement of nonsentinel axillary nodes (NSLNs) in patients with positive SLNs. Methods: We reviewed the records of all patients with invasive breast cancer who underwent SLN biopsy at our institution between 1993 and August 2001. Multivariate analysis was used to identify clinicopathologic features in SLN-positive patients that predict involvement of NSLNs. Results: A total of 131 patients had a positive SLN and underwent completion axillary lymph node dissection. Multivariate analysis revealed that primary tumor >2 cm (P = .009), SLN metastasis >2 mm (P = .024), and lymphovascular invasion (P = .028) were independent predictors of positive NSLNs. The number of SLNs harvested was a significant negative predictor (P = .04). In our model, based on the presence of these factors, the positive predictive value was 100% for a score of 4. Conclusions: The likelihood of positive NSLNs correlates with primary tumor size, size of the largest SLN metastasis, and presence of lymphovascular invasion. A scoring system incorporating these factors may help determine which patients would benefit from additional axillary surgery.
引用
收藏
页码:248 / 254
页数:7
相关论文
共 28 条
  • [1] Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer
    Abdessalam, SF
    Zervos, EE
    Prasad, M
    Farrar, WB
    Yee, LD
    Walker, MJ
    Carson, WB
    Burak, WE
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 182 (04) : 316 - 320
  • [2] ABE O, 1995, NEW ENGL J MED, V333, P1444
  • [3] Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
    Albertini, JJ
    Lyman, GH
    Cox, C
    Yeatman, T
    Balducci, L
    Ku, NN
    Shivers, S
    Berman, C
    Wells, K
    Rapaport, D
    Shons, A
    Horton, J
    Greenberg, H
    Nicosia, S
    Clark, R
    Cantor, A
    Reintgen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1818 - 1822
  • [4] Sentinel node biopsy in breast cancer
    Barnwell, JM
    Arredondo, MA
    Kollmorgen, D
    Gibbs, JF
    Lamonica, D
    Carson, W
    Zhang, P
    Winston, J
    Edge, SB
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (02) : 126 - 130
  • [5] Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun, S
    Pantel, K
    Muller, P
    Janni, W
    Hepp, F
    Kentenich, CRM
    Gastroph, S
    Wischnik, A
    Dimpfl, T
    Kindermann, G
    Riethmuller, G
    Schlimok, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) : 525 - 533
  • [6] Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
    Breslin, TM
    Cohen, L
    Sahin, A
    Fleming, JB
    Kuerer, HM
    Newman, LA
    Delpassand, ES
    House, R
    Ames, FC
    Feig, BW
    Ross, MI
    Singletary, SE
    Buzdar, AU
    Hortobagyi, GN
    Hunt, KK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3480 - 3486
  • [7] CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
  • [8] 2-H
  • [9] Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
    Chu, KU
    Turner, RR
    Hansen, NM
    Brennan, MB
    Bilchik, A
    Giuliano, AE
    [J]. ANNALS OF SURGERY, 1999, 229 (04) : 536 - 541
  • [10] Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
    Cote, RJ
    Peterson, HF
    Chaiwun, B
    Gelber, RD
    Goldhirsch, A
    Castiglione-Gertsch, M
    Gusterson, B
    Neville, AM
    [J]. LANCET, 1999, 354 (9182) : 896 - 900